Median TRPV-1 immunostaining was 0.124% (0.01–0.29%) in IPF patients, which was higher than the median percentage seen in CC and NC patients (Fig 3), however this difference was minimal and did not reach statistical significance (p = 0.53). This evidence concerns the gene TRPV1 and idiopathic pulmonary fibrosis.